Effect and Mechanism of Ganoderma lucidum Spores on Alleviation of Diabetic Cardiomyopathy in a Pilot in vivo Study

References

• Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595–602. doi:10.1016/0002-9149(72)90595-4
   PubMed Web of Science ®Google Scholar
• Yan B, Ren J, Zhang Q, et al. Antioxidative effects of natural products on diabetic cardiomyopathy. J Diabetes Res. 2017;2017.
   Google Scholar
• Whitston M, Chung S, Henderson J, Young B. What can be learned about the impact of diabetes on hospital admissions from routinely recorded data? Diabetic Medicine. 2012;29(9):1199–1205. doi:10.1111/j.1464-5491.2011.03535.x
   PubMedGoogle Scholar
• Westermann D, Walther T, Savvatis K, et al. Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy. Diabetes. 2009;58(6):1373–1381. doi:10.2337/db08-0329
   PubMed Web of Science ®Google Scholar
• Falcão-Pires I, Leite-Moreira AF. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev. 2012;17(3):325–344.
   PubMed Web of Science ®Google Scholar
• Gulsin GS, Athithan L, McCann GP. Diabetic cardiomyopathy: prevalence, determinants and potential treatments. Ther Adv Endocrinol Metab. 2019;10:2042018819834869.
   Web of Science ®Google Scholar
• MacDonald MR, Petrie MC, Hawkins NM, et al. Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J. 2008;29(10):1224–1240. doi:10.1093/eurheartj/ehn156
   PubMed Web of Science ®Google Scholar
• Skali H, Shah A, Gupta DK, et al. Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the atherosclerosis risk in the community study. Circ Heart Fail. 2015;8(3):448–454.
   PubMedGoogle Scholar
• Aksakal E, Akaras N, Kurt M, et al. The role of oxidative stress in diabetic cardiomyopathy: an experimental study. Eur Rev Med Pharmacol Sci. 2011;15(11):1241–1246.
   PubMedGoogle Scholar
• Rajesh M, Mukhopadhyay P, Bátkai S, et al. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol. 2010;56(25):2115–2125. doi:10.1016/j.jacc.2010.07.033
   PubMed Web of Science ®Google Scholar
• Othman AI, El-Sawi MR, El-Missiry MA, Abukhalil MH. Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats. Biomed Pharmacother. 2017;94:362–373. doi:10.1016/j.biopha.2017.07.129
   PubMedGoogle Scholar
• Boudina S, Abel ED. Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord. 2010;11(1):31–39. doi:10.1007/s11154-010-9131-7
   PubMed Web of Science ®Google Scholar
• Ouyang C, You J, Xie Z. The interplay between autophagy and apoptosis in the diabetic heart. J Mol Cell Cardiol. 2014;71:71–80. doi:10.1016/j.yjmcc.2013.10.014
   PubMed Web of Science ®Google Scholar
• Mayer IA, Arteaga CL. The PI3K/AKT pathway as a target for cancer treatment. Annu Rev Med. 2016;67:11–28.
   PubMed Web of Science ®Google Scholar
• Sahu BD, Kumar JM, Sistla R. Baicalein, a bioflavonoid, prevents cisplatin-induced acute kidney injury by up-regulating antioxidant defenses and down-regulating the MAPKs and NF-κB pathways. PLoS One. 2015;10:7. doi:10.1371/journal.pone.0134139
   Google Scholar
• Huynh K, Bernardo BC, McMullen JR, Ritchie RH. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther. 2014;142(3):375–415. doi:10.1016/j.pharmthera.2014.01.003
   PubMed Web of Science ®Google Scholar
• Yu W, Wu J, Cai F, et al. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. PLoS One. 2012;7:12. doi:10.1371/journal.pone.0052013
   Google Scholar
• Sourbier C, Lindner V, Lang H, et al. The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy. Cancer Res. 2006;66(10):5130–5142. doi:10.1158/0008-5472.CAN-05-1469
   PubMed Web of Science ®Google Scholar
• Schabbauer G, Tencati M, Pedersen B, Pawlinski R, Mackman N. PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice. Arterioscler Thromb Vasc Biol. 2004;24(10):1963–1969. doi:10.1161/01.ATV.0000143096.15099.ce
   PubMed Web of Science ®Google Scholar
• Hambright HG, Meng P, Kumar AP, Ghosh R. Inhibition of PI3K/AKT/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells. Oncotarget. 2015;6(9):7195. doi:10.18632/oncotarget.3131
   PubMedGoogle Scholar
• Sanodiya BS, Thakur GS, Baghel RK, Prasad G, Bisen PS. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol. 2009;10(8):717–742. doi:10.2174/138920109789978757
   PubMed Web of Science ®Google Scholar
• Shaher F, Qiu H, Wang S, et al. Associated targets of the antioxidant cardioprotection of ganoderma lucidum in diabetic cardiomyopathy by using open targets platform: a systematic review. Biomed Res Int. 2020;2020.
   Google Scholar
• Guo L, Xie J, Ruan Y, et al. Characterization and immunostimulatory activity of a polysaccharide from the spores of Ganoderma lucidum. Int Immunopharmacol. 2009;9(10):1175–1182. doi:10.1016/j.intimp.2009.06.005
   PubMedGoogle Scholar
• Wang SY, Hsu ML, Hsu HC, Lee SS, Shiao MS, Ho CK. The anti‐tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int j Cancer. 1997;70(6):699–705. doi:10.1002/(SICI)1097-0215(19970317)70:6<699::AID-IJC12>3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• Furusawa E, Chou SC, Furusawa S, Hirazumi A, Dang Y. Antitumour activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in synergenic mice. Phytother Res. 1992;6(6):300–304. doi:10.1002/ptr.2650060604
   Google Scholar
• Li Y-B, Wang R, Wu H-L, et al. Serum amyloid A mediates the inhibitory effect of Ganoderma lucidum polysaccharides on tumor cell adhesion to endothelial cells. Oncol Rep. 2008;20(3):549–556.
   PubMedGoogle Scholar
• Miyazaki T, Nishijima M. Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull (Tokyo). 1981;29(12):3611–3616. doi:10.1248/cpb.29.3611
   PubMedGoogle Scholar
• Sliva D, Loganathan J, Jiang J, et al. Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice. PLoS One. 2012;7(10):e47873. doi:10.1371/journal.pone.0047873
   PubMed Web of Science ®Google Scholar
• Wang F, Zhou Z, Ren X, et al. Effect of Ganoderma lucidum spores intervention on glucose and lipid metabolism gene expression profiles in type 2 diabetic rats. Lipids Health Dis. 2015;14(1):49. doi:10.1186/s12944-015-0045-y
   PubMedGoogle Scholar
• Ho YW, Yeung JSL, Chiu PKY, et al. Ganoderma lucidum polysaccharide peptide reduced the production of proinflammatory cytokines in activated rheumatoid synovial fibroblast. Mol Cell Biochem. 2007;301(1–2):173–179. doi:10.1007/s11010-006-9409-y
   PubMed Web of Science ®Google Scholar
• Wang S-Q, Li X-J, Qiu H-B, et al. Anti-epileptic effect of Ganoderma lucidum polysaccharides by inhibition of intracellular calcium accumulation and stimulation of expression of CaMKII α in epileptic hippocampal neurons. PLoS One. 2014;9:7.
   Google Scholar
• Lin ZB, Wang PY. The pharmacological study of Ganoderma spores and their active components. Beijing Da Xue Xue Bao Yi Xue Ban= Journal of Peking University Health Sciences. 2006;38(5):541–547.
   PubMedGoogle Scholar
• Wang WQ, Wang BX, Zhao XL, Ma XR, Meng DX. The influence of Garoderma lucidum spores on the cell factor IL-6 in the brain of epilepsy mouse. Heilongjiang Med Pharm. 2005;48–49.
   Google Scholar
• Zhao S, Kang YM, Zhang SC, et al. Effect of Ganoderma lucidum spores powder on the expression of IGF-1, NF-κB and apoptosis of nerve cells in the brain from epileptic rat. Chin J Pathophys. 2007;23(8):1153–1156.
   Google Scholar
• Zhang S, Wang S. Effects of Ganoderma lucidumspore powder on astrocyte expression and glutamine synthetase activity in the hippocampal region of epileptic rats. Neural Regeneration Res. 2008;3(12):1304–1307.
   Google Scholar
• Wang S-Q, Li X-J, Zhou S, et al. Intervention effects of ganoderma lucidum spores on epileptiform discharge hippocampal neurons and expression of neurotrophin-4 and N-cadherin. PLoS One. 2013;8(4):e61687. doi:10.1371/journal.pone.0061687
   PubMedGoogle Scholar
• Wang X, Wang X-L, Chen H-L, et al. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. Biochem Pharmacol. 2014;88(3):334–350. doi:10.1016/j.bcp.2014.01.040
   PubMedGoogle Scholar
• Wang H, Wang SQ. Effect of Ganoderma lucidum spores in adjusting the contents of glutamic acid and gammaaminobutyric acid in cerebral cortex and hippocampus of seizures rats. Zhongguo Linchuang Kangfu. 2005;48(9):71–74.
   Google Scholar
• Dong Q, Wang Y, Shi L, et al. A novel water-soluble β-D-glucan isolated from the spores of Ganoderma lucidum. Carbohydr Res. 2012;353:100–105. doi:10.1016/j.carres.2012.02.029
   PubMedGoogle Scholar
• Bao X, Liu C, Fang J, Li X. Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Carbohydr Res. 2001;332(1):67–74. doi:10.1016/S0008-6215(01)00075-1
   PubMedGoogle Scholar
• Bao X-F, Zhen Y, Ruan L, Fang J-N. Purification, characterization, and modification of T lymphocyte-stimulating polysaccharide from spores of Ganoderma lucidum. Chem Pharm Bull (Tokyo). 2002;50(5):623–629. doi:10.1248/cpb.50.623
   PubMedGoogle Scholar
• Bao X-F, Dong Q, Fang J-N. Structure and conformation behavior of a glucan from spores of Ganoderma lucidum (Fr.) Karst. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2000;32(6):557–561.
   PubMedGoogle Scholar
• Bao X, Fang J, Li X. Structural characterization and immunomodulating activity of a complex glucan from spores of Ganoderma lucidum. Biosci Biotechnol Biochem. 2001;65(11):2384–2391. doi:10.1271/bbb.65.2384
   PubMed Web of Science ®Google Scholar
• Bao X-F, Wang X-S, Dong Q, Fang J-N, Li X-Y. Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry. 2002;59(2):175–181. doi:10.1016/S0031-9422(01)00450-2
   PubMed Web of Science ®Google Scholar
• Ye L, Zhang J, Yang Y, et al. Structural characterisation of a heteropolysaccharide by NMR spectra. Food Chem. 2009;112(4):962–966. doi:10.1016/j.foodchem.2008.07.017
   Google Scholar
• Ye L, Zhang J, Ye X, et al. Structural elucidation of the polysaccharide moiety of a glycopeptide (GLPCW-II) from Ganoderma lucidum fruiting bodies. Carbohydr Res. 2008;343(4):746–752. doi:10.1016/j.carres.2007.12.004
   PubMedGoogle Scholar
• Cao Q-Z, Lin Z-B. Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci. 2006;78(13):1457–1463. doi:10.1016/j.lfs.2005.07.017
   PubMed Web of Science ®Google Scholar
• Hikino H, Ishiyama M, Suzuki Y, Konno C. Mechanisms of hypoglycemic activity of Ganoderan B: a glycan of ganoderma lucidum fruit Bodies1. Planta Med. 1989;55(05):423–428. doi:10.1055/s-2006-962057
   PubMedGoogle Scholar
• Hikino H, Konno C, Mirin Y, Hayashi T. Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. Planta Med. 1985;51(04):339–340. doi:10.1055/s-2007-969507
   PubMedGoogle Scholar
• Tomoda M, Gonda R, Kasahara Y, Hikino H. Glycan structures of ganoderans B and C, hypoglycemic glycans of Ganoderma lucidum fruit bodies. Phytochemistry. 1986;25(12):2817–2820. doi:10.1016/S0031-9422(00)83748-6
   Web of Science ®Google Scholar
• Zhou S, Salisbury J, Preedy VR, Emery PW. Increased collagen synthesis rate during wound healing in muscle. PLoS One. 2013;8:3.
   Google Scholar
• Zhao G-J, Hou N, Cai S-A, et al. Contributions of Nrf2 to puerarin prevention of cardiac hypertrophy and its metabolic enzymes expression in rats. J Pharmacol Exp Ther. 2018;366(3):458–469. doi:10.1124/jpet.118.248369
   PubMed Web of Science ®Google Scholar
• Gallo-Oller G, Ordonez R, Dotor J. A new background subtraction method for Western blot densitometry band quantification through image analysis software. J Immunol Methods. 2018;457:1–5. doi:10.1016/j.jim.2018.03.004
   PubMed Web of Science ®Google Scholar
• Xiao J, Deng SB, She Q, et al. Traditional Chinese medicine Qili qiangxin inhibits cardiomyocyte apoptosis in rats following myocardial infarction. Exp Ther Med. 2015;10(5):1817–1823. doi:10.3892/etm.2015.2759
   PubMed Web of Science ®Google Scholar
• Smeaton D. Extending Working Life–Policy Landscape. 2015.
   Google Scholar
• Al-Rasheed NM, Al-Rasheed NM, Hasan IH, Al-Amin MA, Al-Ajmi HN, Mahmoud AM. Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats. Drug Des Devel Ther. 2016;10:2095. doi:10.2147/DDDT.S109287
   PubMed Web of Science ®Google Scholar
• Al-Rasheed NM, Al-Rasheed NM, Hasan IH, et al. Simvastatin ameliorates diabetic cardiomyopathy by attenuating oxidative stress and inflammation in rats. Oxid Med Cell Longev. 2017;2017.
   Google Scholar
• Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson A-M, Rosengren A. Glycaemic control and incidence of heart failure in 20 985 patients with type 1 diabetes: an observational study. The Lancet. 2011;378(9786):140–146. doi:10.1016/S0140-6736(11)60471-6
   PubMedGoogle Scholar
• Wachtel-Galor S, Yuen J, Buswell JA, Benzie IFF. Ganoderma Lucidum (Lingzhi or Reishi). Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. CRC Press/Taylor & Francis; 2011.
   Google Scholar
• Penttilä I, Penttilä K, Rantanen T. Laboratory diagnosis of patients with acute chest pain. Clinical Chemistry and Laboratory Medicine. 2000;38(3):187–197. doi:10.1515/CCLM.2000.027
   PubMedGoogle Scholar
• Morello F, Ravetti A, Nazerian P, et al. Plasma lactate dehydrogenase levels predict mortality in acute aortic syndromes: a diagnostic accuracy and observational outcome study. Medicine. 2016;95:6. doi:10.1097/MD.0000000000002776
   Google Scholar
• Kotlyar AB, Randazzo A, Honbo N, Jin Z-Q, Karliner JS, Cecchini G. Cardioprotective activity of a novel and potent competitive inhibitor of lactate dehydrogenase. FEBS Lett. 2010;584(1):159–165. doi:10.1016/j.febslet.2009.11.022
   PubMedGoogle Scholar
• Young A, Oldford C, Mailloux RJ. Lactate dehydrogenase supports lactate oxidation in mitochondria isolated from different mouse tissues. Redox Biol. 2020;28:101339. doi:10.1016/j.redox.2019.101339
   PubMed Web of Science ®Google Scholar
• Waters E, Doyle J. Systematic reviews of public health in developing countries are in train. BMJ. 2004;328(7439):585. doi:10.1136/bmj.328.7439.585
   PubMedGoogle Scholar
• Goncalves GK, de Oliveira THC, de Oliveira Belo N. Cardiac hypertrophy and brain natriuretic peptide levels in an ovariectomized rat model fed a high-fat diet. Med Sci Monit Basic Res. 2017;23:380. doi:10.12659/MSMBR.907162
   PubMedGoogle Scholar
• Dai H, Chen L, Gao D, Fei A. Phosphocreatine attenuates isoproterenol-induced cardiac fibrosis and cardiomyocyte apoptosis. Biomed Res Int. 2019;2019.
   Google Scholar
• Khanra R, Dewanjee S, Dua TK, et al. Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response. J Transl Med. 2015;13(1):6. doi:10.1186/s12967-014-0364-1
   PubMedGoogle Scholar
• Wang Y, Yang J, Yi J. Redox sensing by proteins: oxidative modifications on cysteines and the consequent events. Antioxid Redox Signal. 2012;16(7):649–657. doi:10.1089/ars.2011.4313
   PubMed Web of Science ®Google Scholar
• Wilson AJ, Gill EK, Abudalo RA, Edgar KS, Watson CJ, Grieve DJ. Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting. Heart. 2018;104(4):293–299. doi:10.1136/heartjnl-2017-311448
   PubMed Web of Science ®Google Scholar
• Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart. 2007;93(8):903–907. doi:10.1136/hrt.2005.068270
   PubMed Web of Science ®Google Scholar
• Tschöpe C, Walther T, Escher F, et al. Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy. FASEB j. 2005;19(14):2057–2059. doi:10.1096/fj.05-4095fje
   PubMedGoogle Scholar
• Gupta SK, Dongare S, Mathur R, et al. Genistein ameliorates cardiac inflammation and oxidative stress in streptozotocin-induced diabetic cardiomyopathy in rats. Mol Cell Biochem. 2015;408(1–2):63–72. doi:10.1007/s11010-015-2483-2
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Kribbs SB, Jr FJ C, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation. 1998;97(14):1382–1391. doi:10.1161/01.CIR.97.14.1382
   PubMed Web of Science ®Google Scholar
• Kubota T, McTiernan CF, Frye CS, et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ Res. 1997;81(4):627–635. doi:10.1161/01.RES.81.4.627
   PubMedGoogle Scholar
• Westermann D, Van Linthout S, Dhayat S, et al. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol. 2007;102(6):500. doi:10.1007/s00395-007-0673-0
   PubMed Web of Science ®Google Scholar
• Huynh K, Kiriazis H, Du X-J, et al. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice. Free Radic Biol Med. 2013;60:307–317. doi:10.1016/j.freeradbiomed.2013.02.021
   PubMed Web of Science ®Google Scholar
• Sari FR, Watanabe K, Thandavarayan RA, et al. 14-3-3 protein protects against cardiac endoplasmic reticulum stress (ERS) and ERS-initiated apoptosis in experimental diabetes. J Pharmacol Sci. 2010;113(4):325–334. doi:10.1254/jphs.10047FP
   PubMedGoogle Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516.
   PubMed Web of Science ®Google Scholar
• Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275(5303):1129–1132. doi:10.1126/science.275.5303.1129
   PubMed Web of Science ®Google Scholar
• Yao H, Han X, Han X. The cardioprotection of the insulin-mediated PI3K/Akt/mTOR signaling pathway. Am J Cardiovasc Drugs. 2014;14(6):433–442.
   PubMed Web of Science ®Google Scholar
• Si R, Tao L, Zhang HF, et al. Survivin: a novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury. J Mol Cell Cardiol. 2011;50(1):16–24. doi:10.1016/j.yjmcc.2010.08.017
   PubMedGoogle Scholar
• Jason SL, Cui W. Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. Development. 2016;143(17):3050–3060. doi:10.1242/dev.137075
   PubMedGoogle Scholar